Hazelnut Pollen Allergy: Late-Winter Tree Pollen and Food Cross-Reactivity

Hazelnut pollen allergy and hazelnut food allergy are immunologically distinct conditions that may or may not coexist in the same patient. Hazelnut pollen allergy is a respiratory condition triggered by inhaling airborne Corylus pollen during the January–March bloom, causing sneezing, nasal congestion, and itchy eyes. It is driven primarily by IgE sensitization to Cor a 1, a PR-10 protein that cross-reacts with birch Bet v 1. Hazelnut food allergy, by contrast, is triggered by eating hazelnuts and can range from mild oral allergy syndrome (if driven by Cor a 1 cross-reactivity) to severe systemic anaphylaxis (if driven by Cor a 8 lipid transfer protein or Cor a 9 seed storage protein, which are heat-stable and resistant to digestion). A patient can have pollen allergy without food allergy, food allergy without pollen allergy, or both. Component-resolved diagnostic testing distinguishes these phenotypes and guides management.

Hazelnut pollen inhalation has not been documented to cause anaphylaxis in the published medical literature. Like other tree pollen allergies, the clinical presentation of hazelnut pollinosis is limited to rhinoconjunctivitis and, in some patients, mild asthma exacerbations. Pollen-mediated anaphylaxis is extraordinarily rare for any tree pollen. However, patients with hazelnut sensitization who eat raw hazelnuts may experience systemic allergic reactions — but this is a food allergy reaction, not a pollen reaction. The critical distinction is which hazelnut protein drives the sensitization: Cor a 1 (PR-10) causes mild oral symptoms that resolve spontaneously, while Cor a 8 (lipid transfer protein) can cause anaphylaxis requiring epinephrine. Any patient who experiences throat swelling, difficulty breathing, or generalized hives after eating hazelnuts should seek emergency care and be evaluated for food allergy.

Hazelnut pollen allergy and birch pollen allergy are not the same condition, but they are closely linked through molecular cross-reactivity. The major hazelnut pollen allergen Cor a 1 and the major birch pollen allergen Bet v 1 share >90% amino acid sequence homology — they are both PR-10 pathogenesis-related proteins with nearly identical three-dimensional structures. This means that a patient primarily sensitized to birch pollen will often have cross-reactive IgE antibodies that also recognize hazelnut Cor a 1, producing positive hazelnut pollen tests and clinical symptoms during the hazel bloom even without independent hazel-specific sensitization. The reverse is also true: primary hazel sensitization can produce cross-reactive birch test results. In clinical practice, Betulaceae pollen allergy is often managed as a family — birch, hazel, and alder — rather than as three separate allergies, because the molecular cross-reactivity is so extensive.

Hazelnut pollen allergy is most common in regions with significant Corylus populations. Oregon's Willamette Valley produces 99% of the US hazelnut crop and has the highest ambient hazelnut pollen concentrations in the country during the February orchard bloom — patients in this region have the greatest exposure and the highest likelihood of clinical sensitization. The Northeast (New York, Pennsylvania, New England) and upper Midwest (Minnesota, Wisconsin, Michigan) have native Corylus americana and Corylus cornuta shrubs in forest understories and hedgerows, producing lower but still clinically relevant pollen levels in March and April. In most of the central, southern, and southeastern United States, hazel is not commercially cultivated and wild stands are sparse or absent — hazelnut pollen is not a significant aeroallergen in these regions.

Cooking hazelnuts prevents allergic reactions if the sensitization is driven by Cor a 1 (PR-10 protein), which is heat-labile. Roasting, baking, or boiling denatures the three-dimensional structure of PR-10 proteins, eliminating the conformational epitopes that IgE antibodies recognize. This is why patients with birch-hazel pollen cross-sensitization can typically eat roasted hazelnuts, hazelnut spreads, and baked goods containing hazelnuts without symptoms — even though raw hazelnuts trigger oral allergy syndrome. However, if the sensitization is driven by Cor a 8 (lipid transfer protein) or Cor a 9 (seed storage protein), cooking does NOT prevent reactions because these proteins are heat-stable and resist both thermal denaturation and digestive degradation. Patients with LTP or seed storage protein sensitization must strictly avoid all forms of hazelnut, cooked or raw, and carry an epinephrine autoinjector.

The severity of hazelnut allergy depends on which protein drives the sensitization, and this can only be determined through component-resolved diagnostic testing ordered by an allergist. Sensitization to Cor a 1 (PR-10 protein) is associated with mild symptoms — oral tingling and itching that resolves within 15–30 minutes without treatment, and seasonal rhinoconjunctivitis during the hazel pollen season. Sensitization to Cor a 8 (lipid transfer protein) or Cor a 9 (seed storage protein) is associated with potentially severe systemic reactions including urticaria, angioedema, respiratory distress, and anaphylaxis. Clinical history also provides clues: if you have only ever experienced mild oral symptoms with raw hazelnuts and tolerate roasted hazelnuts without issue, Cor a 1 sensitization is likely. If you have experienced hives, throat tightness, or breathing difficulty after any hazelnut exposure, Cor a 8 or Cor a 9 sensitization is more likely and requires strict avoidance and epinephrine autoinjector prescription.

Yes, new-onset tree pollen allergy can develop at any age, including middle adulthood and beyond. The underlying mechanism — repeated exposure to pollen in a genetically susceptible individual eventually driving IgE sensitization — operates throughout life. Adults who relocate to Oregon's Willamette Valley or other hazelnut-growing regions and experience their first late-winter respiratory symptoms after the move may be developing new hazelnut or Betulaceae sensitization driven by regional pollen exposure they did not encounter previously. This clinical presentation — 'I never had allergies before I moved to Oregon' — should prompt evaluation with a regional tree pollen panel including hazel, birch, and alder. Adult-onset allergic rhinitis is a well-documented phenomenon and is entirely consistent with the known immunology of sensitization.

The relationship between hazelnut pollen and oral allergy syndrome is driven by the PR-10 protein Cor a 1, which shares extensive structural homology with PR-10 proteins in raw fruits and tree nuts. When a patient is sensitized to hazelnut Cor a 1 through pollen inhalation, the same IgE antibodies recognize structurally similar PR-10 proteins in raw apples (Mal d 1), peaches (Pru p 1), cherries (Pru av 1), hazelnuts, and other plant foods. Eating these raw foods triggers local mast cell degranulation in the oral mucosa, causing the characteristic tingling, itching, and mild swelling of oral allergy syndrome within minutes. The reaction is typically confined to the oropharynx because PR-10 proteins are rapidly degraded by stomach acid and digestive enzymes. This is fundamentally different from primary food allergy driven by heat-stable and digestion-resistant proteins like lipid transfer proteins or seed storage proteins.

Yes, standardized hazelnut (Corylus) pollen extract is available for skin prick testing as part of standard tree pollen panels in US allergy practices. It is typically included alongside birch and alder in the Betulaceae family panel. A positive wheal response (≥3 mm greater than the negative control) confirms IgE sensitization to hazelnut pollen. However, a positive hazelnut skin test does not distinguish between primary hazel sensitization and cross-reactive sensitization driven by birch Bet v 1 homology — the test will be positive in both scenarios. For this reason, component-resolved IgE testing (Cor a 1, Cor a 8, Cor a 9) is often used as a complementary diagnostic tool to clarify the molecular basis of the sensitization and guide clinical management, particularly regarding dietary hazelnut advice.

Hazelnut pollen allergy can worsen over time if left untreated, consistent with the natural history of allergic rhinitis. Persistent nasal mucosal inflammation can lead to increased nasal hyperresponsiveness, meaning that lower pollen concentrations trigger more severe symptoms in subsequent seasons — a phenomenon known as priming. The atopic march means that patients with untreated allergic rhinitis face an elevated risk of developing asthma over time. Additionally, continued pollen exposure can expand the IgE sensitization profile through epitope spreading, potentially increasing the range of cross-reactive foods that trigger oral allergy syndrome. However, effective treatment — particularly allergen immunotherapy — can interrupt this progression. Clinical trials show that immunotherapy not only reduces current symptoms but also decreases the risk of new asthma development and new sensitizations in patients with allergic rhinitis.